Transthyretin amyloid and new treatment options Dec. 15, 2021 Overview Mostrar la transcripción Overview Mayo Clinic cardiologists Martha Grogan, M.D., Melissa A. Lyle, M.D., and Julie L. Rosenthal, M.D., focus on new transthyretin amyloidosis (ATTR) therapies in this video first shown on Medscape Cardiology. For more information or to refer a patient, visit Mayo Clinic Medical Professionals — Cardiovascular Diseases. VID-20525640 Profesionales médicos Transthyretin amyloid and new treatment options